Corporate Law Neutral 5

Pomerantz LLP Targets Nektar and Enphase in New Securities Class Actions

Pomerantz LLP has initiated class action lawsuits against Nektar Therapeutics and Enphase Energy, alleging violations of federal securities laws. The litigation follows a series of financial disclosures and regulatory filings in early 2026 that triggered significant market volatility for both companies.

· 3 min read · Verified by 3 sources · By Legal & RegTech Intelligence Brief Editorial
Share

Key Takeaways

  • Pomerantz LLP has initiated class action lawsuits against Nektar Therapeutics and Enphase Energy, alleging violations of federal securities laws.
  • The litigation follows a series of financial disclosures and regulatory filings in early 2026 that triggered significant market volatility for both companies.

Mentioned

Pomerantz LLP company Nektar Therapeutics company NKTR Enphase Energy company ENPH

Key Intelligence

Key Facts

  1. 1Pomerantz LLP filed class action lawsuits against Nektar Therapeutics and Enphase Energy in March 2026.
  2. 2The litigation alleges violations of federal securities laws through materially false or misleading statements.
  3. 3Nektar Therapeutics (NKTR) filed multiple Regulation FD disclosures in February and March 2026 prior to the suit.
  4. 4Enphase Energy (ENPH) reported its Q4 2025 and FY 2025 results in early February 2026, which preceded the legal action.
  5. 5The lawsuits seek to recover damages for investors who purchased shares during the specified class periods.

Who's Affected

Nektar Therapeutics
companyNegative
Enphase Energy
companyNegative
Pomerantz LLP
companyPositive

Analysis

The legal landscape for mid-cap technology and biotechnology firms has intensified as Pomerantz LLP, a premier law firm specializing in corporate and securities litigation, filed dual class action lawsuits against Nektar Therapeutics (NKTR) and Enphase Energy (ENPH). These filings, announced in late March 2026, represent a significant escalation in shareholder activism aimed at enforcing transparency in corporate disclosures. The lawsuits allege that both companies made materially false or misleading statements regarding their business operations and future prospects, leading to investor losses when the truth was eventually revealed through regulatory filings.

For Nektar Therapeutics, the litigation appears to be tied to a series of disclosures made in February and March 2026. SEC filings indicate that the company released 'Results of Operations' and 'Regulation FD Disclosures' during this period, which often serve as the catalyst for securities litigation if they contradict previous guidance. In the biotech sector, such lawsuits frequently center on the transparency of clinical trial data or the viability of lead drug candidates. Pomerantz’s move suggests a focus on whether Nektar adequately informed the market about the risks associated with its pipeline or the financial stability of its ongoing research partnerships.

For Nektar Therapeutics, the litigation appears to be tied to a series of disclosures made in February and March 2026.

Enphase Energy faces similar scrutiny within the renewable energy sector. The lawsuit follows Enphase's February 2026 financial results, which highlighted the complexities of the global solar market. Securities class actions against solar technology firms often involve allegations of misrepresenting inventory levels, demand in key markets like Europe, or the impact of shifting regulatory incentives for green energy. By targeting Enphase, Pomerantz is signaling to the RegTech and compliance community that even established leaders in the energy transition are not immune to rigorous legal challenges regarding their forward-looking statements.

What to Watch

These cases highlight a broader trend in the Legal & RegTech space: the increasing reliance on automated monitoring systems to identify discrepancies in SEC filings. Law firms like Pomerantz utilize sophisticated data analytics to track 'Regulation FD' disclosures in real-time, allowing them to file suits almost immediately after a stock price correction. This high-frequency litigation model puts immense pressure on corporate legal departments to ensure that every public statement is vetted against historical guidance and current operational realities.

In the short term, both Nektar and Enphase will likely face increased legal expenses and management distraction as they move through the discovery phase. For the broader market, these lawsuits serve as a reminder of the high cost of disclosure failures. RegTech providers are seeing a surge in demand for tools that can perform 'gap analysis' between internal operational data and external communications to prevent the very misstatements that Pomerantz is now litigating. As these cases progress, the industry will be watching for any judicial rulings that further define the boundaries of 'materiality' in the context of volatile sectors like biotech and renewable energy.

Timeline

Timeline

  1. Enphase Financials

  2. Nektar Disclosure

  3. Nektar Financial Update

  4. Litigation Launch

  5. Enphase Suit Filed

Sources

Sources

Based on 3 source articles

Cite This Page

"Pomerantz LLP Targets Nektar and Enphase in New Securities Class Actions." Legal & RegTech Intelligence Brief, March 22, 2026. https://getlegalbrief.com/story/pomerantz-llp-nektar-enphase-class-action

Related Stories

Corporate Law

12 States Sue to Block $81B Paramount-Warner Merger, Citing Antitrust Threat

A coalition of 12 states led by California's AG has filed an antitrust lawsuit to stop the $81 billion Paramount-Warner merger, arguing the combination of two of the last five legacy studios would extinguish competition and harm consumers. The suit tests state enforcement power against a deal cleared by the Trump administration.

Corporate Law

12 States Sue to Halt Paramount-WBD Merger; Antitrust Showdown Begins

California and 11 other states have filed a federal antitrust lawsuit to block Paramount’s proposed acquisition of Warner Bros. Discovery, arguing the deal would harm competition, raise consumer prices, and reduce content quality. Legal experts weigh the complaint’s strengths and the likelihood of success.

Corporate Law

Zillow Investors Sue for Securities Fraud After 16% Drop on FTC Antitrust Claims

A class action accuses Zillow of securities fraud for calling a $100 million Redfin payment a ‘partnership’ when the FTC characterized it as a market‑allocation scheme. The case, filed in June 2026, invokes Sections 10(b) and 20(a) of the Exchange Act and sets a lead plaintiff deadline of August 10, 2026.

Corporate Law

Bribery Scheme Exposes Amazon to Regulatory Risk: $90K Frozen Fund Case

A seller's report of a bribe offer to retrieve $90,000 in frozen funds reveals a shadow market of internal access peddling at Amazon, raising compliance and regulatory questions.

From the Network

Finance

Pomerantz LLP Initiates Class Action Against Apollo Global Management

SaaS

Pomerantz LLP Launches Securities Class Actions Against monday.com and Trip.com

Pomerantz LLP has initiated securities class action investigations and filings against SaaS leader monday.com and travel giant Trip.com. The legal actions allege that the companies made materially fal

Startups

Pomerantz LLP Targets monday.com and Trip.com in Securities Class Actions

Pomerantz LLP has initiated securities class action lawsuits against SaaS leader monday.com and travel giant Trip.com, alleging potential disclosure failures. These legal challenges highlight the incr

How we covered this story

Every story in our legal coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.

Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the legal space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.

Sources are only linked to a story once they clear our classification pipeline at a minimum 35 percent relevance threshold. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.

See something wrong in this story — a wrong fact, a broken source link, a misattributed entity? Report a data issue.

Signal on this pageWhat it tells you
Verified by N sourcesIndependent corroboration count. N≥2 is our confidence floor; N=1 is marked explicitly.
Impact score (1-10)Regulatory + financial + operational weight. 8+ signals an experienced-operator action item.
SentimentFive-tier classification trained on labeled legal-specific corpora.
TimelineWhere applicable, the related-events sequence that contextualizes today's development.